Expansion Therapeutics
is a Massachusetts-based biotechnology company that develops and commercializes small molecule medicines for the treatment of RNA-mediated diseases... Read moreExpansion Therapeutics
is a Massachusetts-based biotechnology company that develops and commercializes small molecule medicines for the treatment of RNA-mediated diseases... Read more
News
Mar 02, 2023
Citybizlist
Expansion Therapeutics: Expansion Therapeutics Announces Key Additions to Scientific Advisory Board
Jan 19, 2022
Citybizlist
Expansion Therapeutics: Expansion Therapeutics Appoints Gary Bridger, Ph.D., to Board
Sep 30, 2021
MarketScreener
Expansion Therapeutics: VC Daily : Expansion Therapeutics Gets $80 Million for RNA-Targeted Drugs
Sep 29, 2021
The Business Journals: Boston
Expansion Therapeutics: Scripps spinout raises $80M for RNA-modulating drugs
May 25, 2021
Business Wire
Press Release: Expansion Therapeutics : Expansion Therapeutics Announces In-Licensing of Two New Research Programs from Scripps Research to Broaden its Portfolio of Small Molecule Medicines
Oct 10, 2020
San Diego Citybizlist
Expansion Therapeutics: Expansion Therapeutics Appoints Renato Skerlj, Ph.D., as Chief Executive Officer
Oct 05, 2020
San Diego Citybizlist
Expansion Therapeutics: Expansion Therapeutics Appoints Renato Skerlj, Ph.D., as Chief Executive Officer
Jun 17, 2019
BioPortfolio
Expansion Therapeutics: Expansion Therapeutics Expands Leadership Team with Two Key Appointments; Names WorldRenowned Scientist Lynne E. Maquat Ph.D. to its Scientific Advisory Board
May 15, 2019
The Business Journals
Expansion Therapeutics: Scripps spin-off company to expand in Palm Beach County
Jan 25, 2019
The Pharma Letter
Expansion Therapeutics: BRIEF-Origenis and Expansion Therapeutics to collaborate
Expansion Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10